A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes

NCT02017171 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

530

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Nephropathies
Coronary Artery Disease

Interventions

DRUG: Allopurinol
DRUG: Placebo

Sponsor

Alessandro Doria

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]